331 related articles for article (PubMed ID: 27529216)
1. The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.
Kölbl AC; Jeschke U; Andergassen U
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529216
[TBL] [Abstract][Full Text] [Related]
2. The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells.
Liu H; Zhang X; Li J; Sun B; Qian H; Yin Z
J Cancer Res Clin Oncol; 2015 Feb; 141(2):189-201. PubMed ID: 24965746
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
Lowes LE; Allan AL
Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biological significance of circulating tumor cells in cancer.
Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
[TBL] [Abstract][Full Text] [Related]
7. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
Chistiakov DA; Chekhonin VP
Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
[TBL] [Abstract][Full Text] [Related]
11. Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients.
Krawczyk N; Meier-Stiegen F; Banys M; Neubauer H; Ruckhaeberle E; Fehm T
Biomed Res Int; 2014; 2014():415721. PubMed ID: 24895575
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1.
Hu B; Tian X; Li Y; Liu Y; Yang T; Han Z; An J; Kong L; Li Y
Cancer Med; 2020 Apr; 9(8):2686-2697. PubMed ID: 32077634
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
Chen J; Cao SW; Cai Z; Zheng L; Wang Q
Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition in tumor metastasis.
Yeung KT; Yang J
Mol Oncol; 2017 Jan; 11(1):28-39. PubMed ID: 28085222
[TBL] [Abstract][Full Text] [Related]
15. Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.
Werner S; Stenzl A; Pantel K; Todenhöfer T
Adv Exp Med Biol; 2017; 994():205-228. PubMed ID: 28560676
[TBL] [Abstract][Full Text] [Related]
16. Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice.
Milano A; Mazzetta F; Valente S; Ranieri D; Leone L; Botticelli A; Onesti CE; Lauro S; Raffa S; Torrisi MR; Marchetti P
Anal Cell Pathol (Amst); 2018; 2018():3506874. PubMed ID: 29682444
[TBL] [Abstract][Full Text] [Related]
17. High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition.
Jiang S; Mao C; Jiang B; Tan Q; Deng B
Technol Cancer Res Treat; 2020; 19():1533033820983086. PubMed ID: 33334252
[TBL] [Abstract][Full Text] [Related]
18. Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells.
Micalizzi DS; Haber DA; Maheswaran S
Mol Oncol; 2017 Jul; 11(7):770-780. PubMed ID: 28544498
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
[TBL] [Abstract][Full Text] [Related]
20. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
